Neurophysiology Devices And Equipment Market Report 2026

Neurophysiology Devices And Equipment Market Overview

• Neurophysiology Devices And Equipment market size has reached to $1.72 billion in 2025 • Expected to grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Rising Prevalence Of Neurological Disorders Fueling The Neurophysiology Device Market • Market Trend: Innovative Products Driving Revenue In The Neurophysiology Devices Market • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Neurophysiology Devices And Equipment Market?

The neurophysiology devices and equipment deal with different functions of the nervous system such as spinal cord and peripheral nerve dysfunction brain alterations and nerve damage. The main technologies involved in neurophysiology devices are electromyography (EMG), electroencephalography (EEG), electrocorticography (ECOG), and evoked potential (EP). Electromyography (EMG) is a diagnostic process to assess the health of muscles and the nerve cells that control them (motor neurons). EMG results could reveal nerve dysfunction, muscle dysfunction, or problems with nerve-to-muscle signal transmission. The neurophysiology devices are either standalone or portable and is used by various end-users such as hospitals and ambulatory surgical centers.

What Is The Neurophysiology Devices And Equipment Market Growth Forecast?

The neurophysiology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to demand for point-of-care diagnostics, rising prevalence of nerve disorders, technological miniaturization, expansion of ambulatory centers, increasing training and education programs. Major trends in the forecast period include rising adoption of portable neurophysiology devices, increased use in intraoperative monitoring, growing demand for wireless recording systems, expansion of neurology and neurodiagnostic labs, focus on early detection of nerve disorders.

Global Neurophysiology Devices And Equipment Market Segmentation

1) By Technology: Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECoG), Evoked Potential (EP) 2) By Modality: Standalone, Portable 3) By End Users: Hospitals, Ambulatory Surgical Centers Subsegments: 1) By Electromyography (EMG): Surface EMG Devices, Needle EMG Devices, Wireless EMG Devices 2) By Electroencephalography (EEG): Conventional EEG Systems, Portable EEG Systems, Wireless EEG Systems 3) By Electrocorticography (ECoG): Grid Electrodes, Strip Electrodes, Subdural Electrodes 4) By Evoked Potential (EP): Visual Evoked Potential (VEP) Devices, Auditory Evoked Potential (AEP) Devices, Somatosensory Evoked Potential (SEP) Devices

What Are The Drivers Of The Neurophysiology Devices And Equipment Market?

The major factor responsible for the growth of the neurophysiology device and equipment market is the increasing prevalence of neurological disorders, worldwide. Neurological disorders are identified as one of the most prevalent disorders out of all the recurring ailments. There are more than 600 neurological disorders like brain tumors, epilepsy, Parkinson's disease, Alzheimer's, etc. These disorders were ranked as the leading cause group of Disability Adjusted Life Years (DALYs), which is the number of years lost due to ill-health, disability, or early death. The increasing number of cases of neurological diseases and the growing count of patients are leading to the increasing demand for the devices used in the treatment of such disorders. For instance, in February 2023, according to Cancer Research UK, a UK-based charity, the average annual incidence of new brain, other CNS, and intracranial tumors in the UK is expected to increase from approximately 12,600 cases between 2023 and 2025 to about 13,600 cases by 2038 to 2040. This would increase the demand for medical devices used in the treatment of neurological disorders, thus driving the Neurophysiology device and equipment market during the forecast period. Government initiatives for next-generation invasive devices are expected to propel the growth of the growth of the neurophysiology devices and equipment market going forward. Government initiatives refer to specific actions, programs, policies, or projects undertaken by government authorities at various levels (local, regional, national, or international) to address specific issues, achieve certain goals, or create positive changes in society. Several government authorities are initiating various healthcare initiatives to support various aspects of next-generation invasive devices. For instance, in 2023, according to the Department of Health and Human Services, a US-based government agency, the National Institutes of Health (NIH) issued a funding opportunity announcement (FOA) to encourage investigators to pursue first-in-human or early-stage clinical studies for next-generation invasive device. Therefore, government initiatives for next-generation invasive devices drive the neurophysiology devices and equipment industry.

Key Players In The Global Neurophysiology Devices And Equipment Market

Major companies operating in the neurophysiology devices and equipment market are Medtronic Plc, Nihon Kohden Corporation, Dr. Langer Medical GmbH, Natus Medical Incorporated, Inomed Medizintechnik, NuVasive Inc, Axon Healthcare Ltd., Bovie Medical Corporation, Neurosign, Neurowave Systems, Cadwell Industries, Brainsway, Checkpoint Surgical, Deymed Diagnostic Inc., EMS Biomedical, Compumedics Limited, Magtism, Langer Medical, Shanghai NCC Medical, Ambu, Blackrock Microsystems, Cognionics, Morningside Medical Equipment, BeckerSmith Medical, Cognivue, Helius Medical Technologies, inTRAvent Medical Partners, Neural Diagnostics Pty Ltd, Irras AB

Global Neurophysiology Devices And Equipment Market Trends and Insights

Major companies operating in the neurophysiology devices and equipment market are developing innovative products such as Evo sEEG electrodes to drive revenues in the market. The Evo sEEG electrode is a high-definition, minimally invasive thin film electrode designed for the diagnosis and treatment of various neurological conditions. For instance, in May 2023, NeuroOne Medical Technologies Corporation, a US-based medical technology company launched Evo sEEG electrodes. The Evo sEEG electrode has the potential for future capabilities for spinal cord stimulation and ablation solutions. This electrode features hi-definition, thin film electrodes that potentially increase signal clarity and provide secure, precise, and less invasive diagnostic procedures for patients with epilepsy, chronic back pain, and Parkinson's disease.

Regional Outlook

North America was the largest region in the neurophysiology devices and equipment market in 2025. Western Europe was the second-largest region in the global neurophysiology devices and equipment market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Neurophysiology Devices And Equipment Market?

The neurophysiology devices and equipment market consist of sales of devices and instruments for nerve conduction studies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.